Skip to main content
Clinical Trials/NCT05579444
NCT05579444TerminatedNot Applicable

Systems Biology of Gastrointestinal and Related Diseases

Viome1 site in 1 country17 target enrollmentStarted: November 11, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
17
Locations
1
Primary Endpoint
Identification of human determinants of gastrointestinal diseases.

Study Overview

Brief Summary

This is a longitudinal observational study on patients with gastrointestinal and related disease. The study will be conducted for at least 10 years, following each participant over time, as they either go through relapses and remissions, or progression of their disease.

Detailed Description

This is a longitudinal, observational study whose main goal is to identify the human and microbial determinants of gastrointestinal diseases. Molecular and metadata will be collected from a large study population at multiple time points. Machine learning will be applied to all data, and models will be evaluated for development of novel diagnostic and therapeutic tools.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Identification of human determinants of gastrointestinal diseases.

Time Frame: Up to 10 years

Identification of biomarkers that indicate gastrointestinal diseases.

Identification of microbial determinants of gastrointestinal diseases.

Time Frame: Up to 10 years

Identification of microbial species that indicate gastrointestinal disease.

Secondary Outcomes

  • Quantify change in microbial species over time post colonoscopy(Up to 10 years.)
  • Prediction of efficacy of biologics in treating IBD.(Up to 10 years.)
  • Development of a molecular test for C. difficile infection (CDI)(Up to 10 years.)

Investigators

Sponsor
Viome
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials